Clinical Trial

Lower-Limb Muscle Mass and Balance Performance

Study acronym: LMBP
Completed
View on ClinicalTrials.gov →
Summary
This study will examine the interaction between lower-limb muscle mass and balance performance in moderately physically active young men. Body composition parameters, including appendicular skeletal muscle mass, leg muscle mass, and the ratio of lower-limb muscle mass to body weight (LMM/BW), will be assessed using bioelectrical impedance analysis. Balance performance will be evaluated using a center-of-pressure-based static balance test, with classifications derived from sway path length and sway area parameters. Participants will be grouped according to balance performance metrics, and muscle mass indicators will be compared between balance-based groups. Correlation analyses will also be conducted to explore associations between muscle mass variables and balance outcomes across the entire sample. It is anticipated that normalized muscle mass indicators, particularly LMM/BW, will demonstrate greater discriminative sensitivity than absolute muscle mass measures in relation to balance performance. The findings are expected to contribute to a more precise understanding of how relative lower-limb muscular capacity relates to postural control in young, physically active populations.
Protocol Amendment History 2 changes
critical Trial status changed: Not Yet Recruiting → Completed 2026-06-09
minor Completion moved earlier: 2026-07-30 -> 2026-06-03 2026-06-09
Trial Details
NCT Number NCT07365605
Lead Sponsor Uludag University
Conditions Lower-limb Muscle Mass and Balance Performance
Enrollment 150 participants
Start Date 2026-02-26
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-06-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-08